GO:0006145 purine nucleobase catabolic process: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006145 describes the biochemical breakdown of purine nucleobases such as adenine and guanine, the nitrogen-containing rings found in DNA and RNA.
• Nucleobase catabolism is tightly linked to nucleobase transport, because cells must import or recycle free bases before they can be degraded.
• Nucleoside phosphorylases are central enzymes that interconvert nucleosides and nucleobases, including unusual reactions such as N7-xanthosine formation.
• Purine nucleobase release by engineered gut bacteria can promote butyrate generation and colonic wound healing, showing a microbiome dimension.
• In pathogens, purine salvage and catabolism pathways are drug targets, as shown for de novo purine biosynthesis in tuberculosis and nucleobase transport in malaria.
• CRISPR knockout, point-mutation, knock-in and overexpression models allow causal testing of genes acting in purine nucleobase catabolic process.
Description
GO:0006145, purine nucleobase catabolic process, is the biological process in which purine nucleobases such as adenine and guanine are chemically broken down. Purine nucleobases are one of the two classes of nitrogen-containing ring compounds found in DNA and RNA, and their catabolism is part of the broader purine metabolic network that balances nucleotide supply, salvage and degradation. Because free nucleobases cannot freely diffuse across most biological membranes, their catabolism is functionally coupled to dedicated nucleobase transport systems in organisms ranging from protozoan parasites to mammals. This coupling makes the pathway a point of intersection between nutrient acquisition, nucleic acid turnover and cellular nitrogen handling. For researchers, GO:0006145 matters because defects or deliberate alterations in purine nucleobase breakdown can change the availability of substrates for nucleotide synthesis, influence drug activation or detoxification, and shape host-microbe interactions. Nucleoside phosphorylases, which catalyze reversible phosphorolysis of nucleosides into nucleobases and sugars, are key entry points into this process and have been shown to generate noncanonical products such as N7-xanthosine. In microbial systems, engineering purine nucleobase release can alter fermentation end products and tissue repair responses. In infectious disease, purine pathways are actively pursued as targets, including de novo purine biosynthesis in Mycobacterium tuberculosis and nucleobase transport in Plasmodium falciparum. This article integrates the QuickGO definition of GO:0006145 with verified experimental literature to summarize the mechanism, key genes, disease links, model systems and research methods relevant to purine nucleobase catabolic process. It is written for scientists who need a precise, citation-anchored overview for experimental design, grant writing or target evaluation.
purine nucleobase catabolic process At A Glance
| GO ID | GO:0006145 |
|---|---|
| GO term | purine nucleobase catabolic process |
| Ontology | biological_process |
| Definition | The chemical reactions and pathways resulting in the breakdown of purine nucleobases, one of the two classes of nitrogen-containing ring compounds found in DNA and RNA, which include adenine and guanine. |
| Synonyms | purine base breakdown; purine base catabolic process; purine base catabolism; purine base degradation |
| Major function | Degradation of free purine nucleobases such as adenine and guanine, contributing to purine homeostasis and nitrogen metabolism. |
| Related transport | Nucleobase transporters are required for uptake or release of purine bases and are functionally coupled to catabolic pathways. |
| Key enzyme class | Nucleoside phosphorylases interconvert nucleosides and nucleobases and can produce unusual purine derivatives. |
| Disease relevance | Purine pathway enzymes and transporters are studied in tuberculosis, malaria and host-microbe interactions. |
What Is GO:0006145?
In plain terms, GO:0006145 purine nucleobase catabolic process is the set of chemical reactions and pathways that result in the breakdown of purine nucleobases, including adenine and guanine. The term covers the enzymatic steps that convert these free bases into downstream catabolic products, as distinct from purine nucleotide biosynthesis or salvage. It is a biological_process term in the Gene Ontology, with synonyms including purine base breakdown, purine base catabolic process, purine base catabolism and purine base degradation.
Why Is purine nucleobase catabolic process Important in Cell Biology?
Purine nucleobase catabolic process is important because it controls the fate of free adenine and guanine, which are central to nucleotide homeostasis, nitrogen balance and, in some organisms, host-microbe signaling. Because nucleobases require transporters to cross membranes, catabolism is integrated with uptake and release systems. Experimental work has shown that nucleoside phosphorylases can catalyze unexpected reactions such as N7-xanthosine synthesis, expanding the known chemistry of purine nucleobase metabolism. In microbial communities, engineering purine nucleobase release can shift fermentation toward butyrate and improve colonic wound healing in models of DSS-induced injury. In pathogens, purine pathways remain attractive drug targets, including de novo purine biosynthesis in M. tuberculosis and nucleobase transport in malaria parasites. Together, these findings make GO:0006145 a high-value area for mechanistic, therapeutic and microbiome research.
• Maintains purine homeostasis by removing or recycling free adenine and guanine.
• Provides substrates and intermediates for nucleotide salvage and downstream metabolism.
• Is functionally coupled to nucleobase transport across membranes in parasites and mammals.
• Can be engineered in gut bacteria to promote butyrate generation and colonic wound healing.
• Represents a drug target space in infectious disease, including tuberculosis and malaria.
• Influences microbial fermentation and host-microbe metabolic cross-talk.
• Involves nucleoside phosphorylases with broad substrate tolerance and unusual product formation.
• Provides a defined GO term for annotation of enzymes, transporters and pathways in genome-scale studies.
What Happens During purine nucleobase catabolic process?
Substrate availability and nucleobase transport
In simple terms: Before a purine base can be broken down, it usually has to get into the cell or be released from a nucleoside.
Purine nucleobase catabolism begins with the availability of free purine bases such as adenine and guanine. Because nucleobases are polar molecules, their movement across biological membranes depends on specific nucleobase transporters, which have been reviewed across organisms. In mammals, molecular studies have defined nucleobase transport systems that mediate uptake and release of bases, linking transport to intracellular catabolic and salvage pathways. In the intraerythrocytic malaria parasite, purine nucleobase transport has been characterized as a route for acquiring host-derived purines. Thus, transport steps set the substrate supply for GO:0006145.
Phosphorolysis and nucleoside phosphorylase chemistry
In simple terms: Enzymes called nucleoside phosphorylases cut nucleosides into a base and a sugar phosphate, feeding the base into catabolism.
Nucleoside phosphorylases catalyze the reversible phosphorolysis of nucleosides, generating a free nucleobase and a phosphorylated sugar. This reaction is a central entry point into purine nucleobase catabolic process because it produces the free bases that are subsequently degraded. Westarp et al. showed that nucleoside phosphorylases can make N7-xanthosine, demonstrating that these enzymes can generate noncanonical purine nucleobase derivatives. Such chemistry expands the range of substrates and products relevant to GO:0006145 and provides mechanistic insight into how purine bases are processed.
Oxidative and hydrolytic breakdown of purine bases
In simple terms: Once free, purine bases are chemically modified and broken down into simpler products.
The core of GO:0006145 is the enzymatic breakdown of purine nucleobases into downstream metabolites. The QuickGO definition specifies that this process includes the chemical reactions and pathways resulting in the breakdown of purine nucleobases such as adenine and guanine. Experimental studies of purine metabolism in pathogens and microbes provide context for these reactions: de novo purine biosynthesis in Mycobacterium tuberculosis is a validated target area, and purine nucleobase release by engineered Escherichia coli affects butyrate generation and colonic wound healing. These examples illustrate how flux through purine base catabolic steps can have physiological consequences beyond simple waste removal.
Integration with nucleotide salvage and nitrogen metabolism
In simple terms: The breakdown of purine bases is not isolated; it connects to recycling pathways and nitrogen handling.
Purine nucleobase catabolic process is integrated with salvage pathways that recover bases for nucleotide synthesis and with nitrogen metabolism. Nucleobase transporters are required for both uptake and release, meaning catabolic flux can be balanced against salvage demand. In microbial systems, modifying purine nucleobase release can redirect metabolism toward butyrate production and improve colonic wound healing in DSS-treated models. In parasites, nucleobase transport supports purine acquisition, which is essential because some parasites cannot synthesize purines de novo. These connections place GO:0006145 within a broader metabolic network rather than as an isolated degradative route.
Key Genes Involved in GO:0006145 purine nucleobase catabolic process
The following genes and proteins are experimentally or functionally associated with purine nucleobase catabolic process, nucleobase transport, or closely related purine metabolism pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Nucleoside phosphorylase enzymes | Catalyze phosphorolysis of nucleosides to free nucleobases | Generate substrates for purine nucleobase catabolism and can form unusual products such as N7-xanthosine |
| Nucleobase transporters | Mediate uptake and release of purine bases across membranes | Functionally coupled to catabolic and salvage pathways in multiple organisms |
| Mammalian nucleobase transport systems | Transport purine and pyrimidine bases in mammalian cells | Defined at the molecular level and relevant to drug disposition and purine homeostasis |
| Malaria parasite nucleobase transporters | Import host purine nucleobases | Characterized in intraerythrocytic Plasmodium falciparum as a purine acquisition route |
| Mycobacterium tuberculosis purine biosynthesis genes | De novo purine biosynthesis | Validated target space for tuberculosis treatment |
| E. coli purine nucleobase release genes | Modulate purine nucleobase export | Engineered strains promote butyrate generation and colonic wound healing |
| CBASS-associated nucleobase conjugation genes | Deazaguanylation and nucleobase-protein conjugation | Required for type IV CBASS immunity, linking nucleobase chemistry to immune signaling |
| DNA methyltransferase genes | Nucleoside-driven specificity of DNA methylation | Nucleoside availability can influence epigenetic marking |
| Purine salvage pathway genes | Recover purine bases for nucleotide synthesis | Balance catabolism versus salvage |
| Purine catabolic enzyme genes | Break down adenine and guanine derivatives | Core components of GO:0006145 |
| Nucleoside transport genes | Move nucleosides into cells | Supply substrates for phosphorylases and catabolism |
| Xanthine-related metabolic genes | Process xanthine and related purines | Connected to N7-xanthosine chemistry |
| Guanine deaminase-like genes | Deaminate guanine to xanthine | Contribute to purine base breakdown |
| Adenine deaminase-like genes | Deaminate adenine to hypoxanthine | Contribute to purine base breakdown |
| Uric acid pathway genes | Downstream purine catabolism | Terminal steps of purine degradation in some organisms |
| Purine-responsive regulatory genes | Sense purine levels and adjust pathway flux | Link catabolism to cellular homeostasis |
How Is purine nucleobase catabolic process Regulated?
Purine nucleobase catabolic process is regulated at multiple levels, including substrate availability through nucleobase transporters, enzyme expression and activity of nucleoside phosphorylases, and integration with salvage and de novo biosynthesis pathways. In microbial communities, altering purine nucleobase release can shift metabolic output toward butyrate and influence host tissue repair. In parasites, nucleobase transport capacity determines access to host purines, which is essential for survival. These layers of control ensure that purine catabolism is balanced against nucleotide demand and nitrogen availability.
purine nucleobase catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Mycobacterium tuberculosis purine biosynthesis genes | Tuberculosis | Knockout and point-mutation models in mycobacteria |
| Plasmodium falciparum nucleobase transporters | Malaria | Transport assays and knockout parasite lines |
| E. coli purine nucleobase release genes | Colonic wound healing and butyrate generation | Engineered bacterial strains in DSS colitis models |
| CBASS-associated nucleobase conjugation genes | Type IV CBASS immunity | Knockout and knock-in bacterial systems |
| Nucleoside phosphorylase genes | Purine metabolism and unusual nucleobase products | Recombinant enzyme assays and overexpression models |
Tuberculosis and purine pathway targeting
Mycobacterium tuberculosis depends on purine metabolism for growth and survival, and de novo purine biosynthesis has been pursued as a therapeutic target. Lamprecht et al. reported that targeting de novo purine biosynthesis is a viable strategy for tuberculosis treatment. Although this work focuses on biosynthesis rather than catabolism, it establishes the broader principle that purine pathway flux can be therapeutically exploited in tuberculosis, and it motivates investigation of purine nucleobase catabolic process in mycobacterial physiology.
Malaria and purine acquisition
Intraerythrocytic malaria parasites cannot synthesize purines de novo and rely on host purine salvage, which requires nucleobase transport. Downie et al. characterized purine nucleobase transport in the intraerythrocytic malaria parasite, showing that transport is a critical route for purine acquisition. Because transport is coupled to downstream catabolic and salvage steps, enzymes acting in GO:0006145 may influence parasite purine balance and represent potential intervention points.
Host-microbe interactions and colonic wound healing
Engineered gut bacteria that release purine nucleobases can alter fermentation and host responses. Lee et al. showed that E. coli genetically modified for purine nucleobase release promotes butyrate generation and colonic wound healing during DSS insult. This links purine nucleobase metabolism, including catabolic and release pathways, to epithelial repair and microbiome-based therapeutic strategies.
Immune signaling and nucleobase conjugation
Nucleobase chemistry can directly participate in immune signaling. Wassarman et al. demonstrated that deazaguanylation is a nucleobase-protein conjugation required for type IV CBASS immunity. This finding connects purine nucleobase derivatives to bacterial antiviral defense and highlights that nucleobase modifications are not merely metabolic waste products but can be signaling molecules.
From purine nucleobase catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene block purine nucleobase catabolism? | CRISPR knockout cell line or bacterial knockout |
| Does a specific active-site residue control substrate specificity? | Point-mutation knock-in of the catalytic residue |
| Can a tagged enzyme be used to track pathway localization? | Tagged knock-in with fluorescent or affinity tag |
| Does overexpression increase flux through purine nucleobase breakdown? | Overexpression cell line or bacterial strain |
| Does a disease-associated variant alter catabolic activity? | Knock-in of the patient variant followed by metabolic assays |
| Can purine nucleobase release be engineered to alter fermentation? | Engineered bacterial strain in a defined community or host model |
How to Study the purine nucleobase catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Enzyme activity assay | Catalytic conversion of nucleosides or nucleobases | Characterizing nucleoside phosphorylases and catabolic enzymes |
| Nucleobase transport assay | Uptake or release of purine bases | Studying transporters in parasites and mammalian cells |
| CRISPR knockout | Loss-of-function phenotype | Testing whether a gene is required for purine nucleobase catabolism |
| Point-mutation knock-in | Effect of a specific residue change | Mapping catalytic and substrate-binding residues |
| Tagged knock-in | Protein localization and interactions | Tracking enzymes or transporters in cells |
| Overexpression | Gain-of-function phenotype | Increasing flux through catabolic or release pathways |
| Microbial co-culture | Metabolite cross-feeding and fermentation output | Testing purine nucleobase release effects on butyrate |
| Metabolomics | Levels of purine bases and downstream metabolites | Measuring pathway flux and substrate accumulation |
Metabolic and enzyme assays
Direct measurement of purine nucleobase catabolic process relies on enzyme assays using purine nucleobases or nucleosides as substrates. Nucleoside phosphorylase reactions can be monitored by detecting products such as N7-xanthosine or canonical bases. Transport assays are used to measure nucleobase uptake and release, as demonstrated in malaria parasites and mammalian systems. These assays provide kinetic and substrate-specificity data for genes annotated to GO:0006145.
Genetic perturbation and phenotyping
Knockout, point-mutation, knock-in and overexpression models allow causal testing of genes involved in purine nucleobase catabolism. For example, engineered E. coli with modified purine nucleobase release can be tested for butyrate generation and wound healing in DSS models. In mycobacteria, genetic targeting of purine biosynthesis has been used to evaluate growth and survival effects. Similar strategies can be applied to catabolic genes to define their contribution to pathway flux.
Transport and localization studies
Because nucleobase catabolism is coupled to transport, localization and transport studies are important. Molecular characterization of mammalian nucleobase transport systems has defined how bases enter and exit cells, and purine nucleobase transport in malaria parasites has been measured directly. Fluorescent or affinity tagging of transporters and enzymes can reveal subcellular localization and membrane topology.
Microbiome and host interaction models
Purine nucleobase metabolism can be studied in microbial communities and host models. Lee et al. used E. coli genetically modified for purine nucleobase release to promote butyrate generation and colonic wound healing during DSS insult. Such models combine bacterial genetics with host phenotyping and can be extended to test genes acting in GO:0006145.
How CRISPR Can Be Used to Study GO:0006145 purine nucleobase catabolic process
Knockout
CRISPR knockout is used to delete candidate genes acting in purine nucleobase catabolic process, such as nucleoside phosphorylases or nucleobase transporters. Loss-of-function models allow researchers to test whether a gene is required for breakdown of adenine or guanine and to measure downstream metabolic consequences. This approach is directly analogous to genetic targeting of purine pathway genes in pathogens and to engineered bacterial strains with altered purine nucleobase release.
Point Mutation
Point-mutation models introduce specific amino acid changes to test catalytic residues or substrate-binding sites in enzymes such as nucleoside phosphorylases. These models are valuable for distinguishing enzyme activity from scaffolding functions and for validating mechanism inferred from structural or biochemical studies.
Knock-in
Knock-in strategies can add tags, reporters or disease-associated variants to genes involved in purine nucleobase catabolism. Tagged knock-ins enable localization and interaction studies, while variant knock-ins allow functional testing of alleles that may alter pathway flux. These approaches complement transport and enzyme assays used in parasite and mammalian systems.
Overexpression
Overexpression models increase the level of a candidate enzyme or transporter to test gain-of-function effects on purine nucleobase catabolic process. Overexpression can reveal rate-limiting steps, drive flux toward specific products, or mimic metabolic states observed in microbial communities where purine nucleobase release alters fermentation.
How EDITGENE Supports purine nucleobase catabolic process Research
Researchers studying purine nucleobase catabolic process-related genes often need to determine whether a candidate gene is causally involved in the breakdown of adenine, guanine or related purine bases, or whether it acts indirectly through transport, salvage or signaling. Rigorous causal testing requires well-controlled genetic models, including knockout, point-mutation, knock-in and overexpression cell lines, combined with metabolic and transport assays. EDITGENE provides these models and supporting bioinformatics to accelerate hypothesis-driven research on GO:0006145.
Contact EDITGENE today to design your custom CRISPR model for purine nucleobase catabolic process research.
Frequently Asked Questions About purine nucleobase catabolic process
What is GO:0006145 purine nucleobase catabolic process?
GO:0006145 is a Gene Ontology biological_process term describing the chemical reactions and pathways that break down purine nucleobases such as adenine and guanine, which are nitrogen-containing rings found in DNA and RNA.
What genes are involved in purine nucleobase catabolic process?
Genes involved include nucleoside phosphorylases that produce free nucleobases, nucleobase transporters that move bases across membranes, and purine pathway genes studied in pathogens and microbes.
Why is purine nucleobase catabolism important?
It maintains purine homeostasis, supports nucleotide salvage and nitrogen balance, and can influence host-microbe interactions and disease processes.
How are purine nucleobases transported?
Purine nucleobases require specific nucleobase transporters to cross membranes, as reviewed across organisms and characterized in mammals and malaria parasites.
What enzymes break down purine nucleobases?
Nucleoside phosphorylases catalyze phosphorolysis of nucleosides to free bases and can generate unusual products such as N7-xanthosine; downstream catabolic enzymes further degrade the bases.
Is purine nucleobase catabolism a drug target?
Purine pathways are pursued as drug targets in infectious disease, including de novo purine biosynthesis in tuberculosis and nucleobase transport in malaria.
How does purine nucleobase metabolism affect the gut microbiome?
Engineered E. coli that release purine nucleobases can promote butyrate generation and colonic wound healing during DSS insult, linking purine metabolism to microbiome-host interactions.
Can CRISPR be used to study purine nucleobase catabolic process?
Yes, CRISPR knockout, point-mutation, knock-in and overexpression models allow causal testing of genes acting in purine nucleobase catabolism, analogous to genetic studies of purine pathways in pathogens and microbes.
What diseases are linked to purine nucleobase metabolism?
Research links purine pathways to tuberculosis, malaria, colonic wound healing and bacterial immune signaling through nucleobase conjugation.
What methods study purine nucleobase catabolic process?
Enzyme activity assays, nucleobase transport assays, CRISPR genetic models, metabolomics and microbial co-culture are commonly used.
Conclusion
GO:0006145 purine nucleobase catabolic process defines the breakdown of purine nucleobases such as adenine and guanine, a process tightly coupled to nucleobase transport, nucleotide salvage and nitrogen metabolism. Experimental studies show that nucleoside phosphorylases can generate unusual purine derivatives, that engineered purine nucleobase release can improve colonic wound healing, and that purine pathways are drug targets in tuberculosis and malaria. These findings make the pathway relevant to metabolism, infectious disease and microbiome research. For researchers, causal dissection of GO:0006145 requires well-controlled genetic models and quantitative metabolic assays. CRISPR knockout, point-mutation, knock-in and overexpression cell models, combined with library screening and bioinformatics, provide a practical route to define gene function and therapeutic potential in purine nucleobase catabolism.
References
- 1. Lamprecht DA et al.. 2025. Targeting de novo purine biosynthesis for tuberculosis treatment.. Nature 644(8075):214-220 PMID: 40533558
- 2. Wassarman DR et al.. 2025. Deazaguanylation is a nucleobase-protein conjugation required for type IV CBASS immunity.. Science 389(6767):1347-1352 PMID: 40997174
- 3. de Koning H et al.. 2000. Nucleobase transporters (review).. Mol Membr Biol 17(2):75-94 PMID: 10989458
- 4. Westarp S et al.. 2024. Nucleoside Phosphorylases make N7-xanthosine.. Nat Commun 15(1):3625 PMID: 38684649
- 5. Gade M et al.. 2023. Nucleoside-Driven Specificity of DNA Methyltransferase.. Chembiochem 24(22):e202300094 PMID: 37548117
- 6. Inoue K. 2017. Molecular Basis of Nucleobase Transport Systems in Mammals.. Biol Pharm Bull 40(8):1130-1138 PMID: 28768993
- 7. Lee JS et al.. 2025. E. coli genetically modified for purine nucleobase release promotes butyrate generation and colonic wound healing during DSS insult.. Gut Microbes 17(1):2490211 PMID: 40247632
- 8. Downie MJ et al.. 2008. Purine nucleobase transport in the intraerythrocytic malaria parasite.. Int J Parasitol 38(2):203-9 PMID: 17765902
